NCT00000650View on ClinicalTrials.gov

An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients

NACompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 1996

Conditions

HIV Infections

Interventions

DRUG

Ditiocarb sodium

Trial Locations (1)

21287

Johns Hopkins Adult AIDS CRS, Baltimore

Sponsors

Collaborators (1)

Connaught Laboratories

All Listed Sponsors

collaborator

Connaught Laboratories

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000650 - An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients | Biotech Hunter | Biotech Hunter